๐ The TRANSCAN-3 Symposium E-Abstract Book is available!
๐ Best Poster Awards:
๐ Karyna Volkava (TALETE)
๐ Carolin Birr (TENACITY)
๐ Marta Chivite-Lacaba (XPANTHER)
๐ฌ 32 cancer research projects showcased in Bologna.
https://t.co/8S8rdxenRv
๐ฌ Pancreatic cancer prevention & screening took centre stage in Barcelona on 17 October.
Hugo Soares, TRANSCAN-4 co-coordinator, highlighted the network's contribution to the EU Cancer Mission.
๐๏ธ 12 pancreatic cancer research projects funded!
๐ https://t.co/slJ2hR4f6q
On #WorldBreastCancerDay, we highlight international collaboration in cancer research.
๐ฌ 10 breast cancer projects supported through 6 TRANSCAN calls, involving 13 countries.
Discover the research:
https://t.co/NXbV4ATJXF
#TRANSCAN4
European Parliament discussions highlight the need for sustained investment in cancer research and stronger European collaboration.
Since 2011, TRANSCAN has supported:
141 transnational projects
700+ research groups
20+ countries
Discover #TRANSCAN4 ๐ https://t.co/3YQnTlru3d
The programme includes poster sessions, patient engagement, TRANSCAN impact assessment and an AI workshop for early-career researchers.
Jointly organised by @IsraelMOH & @ministerosalute, with @AlleConCancro & AICIB .
๐ Bologna | ๐๏ธ 20โ22 Oct 2026
๐๏ธ #TRANSCAN-3 Final Symposium | Bologna, 20โ22 October 2026
TRANSCAN-3 comes together for its Final Symposium!
Coordinators from JTC2021 and JTC2024 will share their research and results, as TRANSCAN-4 continues the networkโs next chapter.
#CancerResearch
๐ข The TRANSCAN-4 Joint Transnational Call #JTC2026 is officially open today!
๐ฌ Topic:
โTranslational Research on Cancer Metabolism: Multidisciplinary Approaches for Diagnosis and Treatmentโ
๐๏ธ Pre-proposals due: 21 July 2026
More info ๐
https://t.co/JviF0qNQ2t
#TRANSCAN4
๐ฎ๐น Save the date: TRANSCAN-3 JTC 2023 symposium in Milan on Oct 28โ29.
๐ฅ Projects, workshops, training & more โ especially for early career researchers.
๐EPILUNAR is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC and is aimed at discovering novel biomarkers to identify mNSCLC patients who will benefit from immune checkpoint inhibitors (ICIs).
Click here to know more about the project ๐ https://t.co/whWiOtFC4s
EPILUCAFS is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC and is aimed at investigatin how chronic inflammation related to psychosocial stress shapes the tumour microenvironment and tumour draining lymph nodes in lung cancer.
To know more ๐ https://t.co/Y8yxfUbxAX
EPI_T-ALL is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC and is aimed at characterizing critical molecular events that drive the progression of human T-cell progenitors from normal to outright malignant states.
To know more ๐ https://t.co/DH6PKZG06o
DICE is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC, and it aims to untangle the epigenomic impact of dietary intervention (namely anti- inflammatory diet, AID) for the identification of new epigenetic therapeutic targets.
To know more ๐ https://t.co/oZseEMRsEv
๐ Last 10 and 11 October, the SEC for the Transcan-3 JTC 2024 gathered in Catania for the pre-proposal evaluation of JTC 2024 of TRANSCAN-3.
๐ก Today, the Funders will decide, based on the ranking list, how many proposals will advance to the second stage.
DC2M-TAEC is one of the 13 projects funded by the 2023 TRANSCAN-3 JTC, and it aims to develop a platform to simultaneously generate methylation and sequencing results.
Click here to know more ๐ https://t.co/aRAxvuPisp
Today is World Cancer Research Day, an event that aims to promote global collaboration for cancer research and to increase survival, facilitate access to scientific advances worldwide, and reduce the global burden of cancer.
Learn about our commitment ๐ https://t.co/3YQnTlru3d
The first Meeting of the SEC for the Transcan-3 JTC 2024 is approaching! On October 10th - 11th, 2024, we will celebrate our second Symposium in Catania, Italy, featuring the projects of our call JTC 2022 and the evaluation of pre-proposals of our latest call JTC 2024.
๐ข The Transcan-3 JTC 2023 has successfully concluded, selecting 13 consortia for funding, with an allocation of almost 17 million euros dedicated to advancing translational research on cancer epigenetics.
Discover the awarded projects on our website ๐ https://t.co/NxohEqQgHd
โ๐ก๐ฒ๐ ๐๐ฟ๐ผ๐ป๐๐ถ๐ฒ๐ฟ๐ ๐ถ๐ป ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐๐บ๐บ๐๐ป๐ผ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐โ, organized by ISI and SITC, is set to take place on ๐ฆ๐ฒ๐ฝ๐๐ฒ๐บ๐ฏ๐ฒ๐ฟ ๐ญ๐๐, prior to the 7th European Congress of Immunology (ECI) in Dublin, Ireland. To register: https://t.co/zlHUsfoil0
Don't forget to subscribe toย Transcan-3ย newsletter here:ย https://t.co/xI6Uka9eqI It is the best way to stay updated on news, events and funding opportunities, such as the upcoming JTC2024. Stay tuned! #cancer#oncology#research